FDA Approves Kedrion’s Bolognana Facility for Production of First and Only Treatment for PLGD-1, Ryplazim®
Press Releases
November 21, 2024

FDA Approves Kedrion’s Bolognana Facility for Production of First and Only Treatment for PLGD-1, Ryplazim®

FORT LEE, N.J., Nov. 19, 2024 /PRNewswire/ -- Kedrion Biopharma Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved the company's manufacturing facility in

bradford

The Bradford Era

Local & Social